臨床免疫檢驗裝置市場 是由出版商Trimark Publications在2010年10月所出版的。
這份英文市場調查報告書包含165 pages 價格從美金3400起跳。
本報告，彙整了臨床免疫檢驗裝置市場的概要與規模、技術動向、今後的展望、參與企業的檔案資料、美國•日本•歐洲的各市場動向等，由下列摘要形式闡述。 封面圖片：  第1章 概要
第2章 體外診斷用臨床免疫檢驗裝置市場
第3章 體外診斷用臨床免疫檢驗裝置市場分析
- 市場
- 全球市場
- 全球臨床免疫檢驗市場的促進因子
- 全球市場的今後展望
- 美國
- 歐洲
- 各國市場
- 亞洲的醫療市場概要
- 拉丁美洲的診斷市場概要
- 臨床免疫檢驗裝置領域
- 業界動向
- 主要企業
- 市場的特殊化
- 收益與補助
- 企業
- 臨床免疫檢驗裝置的檢驗的今後展望
- 長期變化
- 市場促進因子
- 成長的極限
- IVD市場的關注領域
- 主要技術
- 分析裝置的整合：化學與免疫檢測
- 結論
第4章 領域別臨床免疫檢驗裝置市場動向
- 市場分析：規模、成長、比例、競爭企業
- 免疫化學分析裝置
- 大型免疫化學分析裝置
- 分次式免疫檢驗裝置
- 小∼中型免疫檢驗裝置
- 其他
第5章 重要的技術動向
- 免疫檢驗的技術創新
- 免疫檢出技術平台
- 新範例
- 整合工作站
- 節省人力的實驗室自動化
- 實驗室資訊系統
- 生物感應器技術
- 資料管理問題
第6章 臨床免疫檢驗裝置部門的商業動向
- 主要發展動向
- 部門整合
- 診斷檢驗的擴大動向
- 日本的試劑與硬體業務
- 新產品
- 收購、專利契約、社內開發以及合作
- 臨床免疫檢驗裝置的檢驗程度
- 政府的規範
- 市場的普及擴大
- 在歐洲進行業務的成本
- 歐洲診斷檢驗的促進因子
- 歐洲的補助動向
- 歐洲的成本控制對策
- Medicare支出動向／Medicare Part B支出動向
- 連接性國際財團
第7章 企業檔案資料
- Abbott Diagnostics
- Bayer Healthcare
- Beckman Coulter
- BioMerieux
- Dade Behring
- Bio-Rad laboratories
- Olympus America, Inc.
- Ortho-Clinical Diagnostics
- Phadia AB
- Randox Laboratories
- Roche Diagnostics
- Tosoh Corporation
- Siemens AG
第8章 臨床免疫檢驗裝置領域：動向與預測
- 自動裝置平台的進化
- 臨床實驗裝置的試劑與配件市場
- 條碼閱讀器
- 免疫檢驗的檢測與檢出
- 機器人化
- 與中央實驗室分離
- 模組自動化
- 免疫檢驗裝置的結構
- 臨床免疫檢驗的促進因子
- 新技術的影響
- 新動向
第9章 產品上市
圖表
Abstract
Clinical immunoanalyzer analysis is one of the most important functions of
clinical laboratory analysis. By all accounts, automated immunoassay testing
is the most rapidly developing of the traditional clinical laboratory sectors.
Clinical immunoanalyzer analysis usually refers to determining the
concentration or activity of protein, carbohydrate, lipid, enzyme or small
molecule in easily collected body fluids, such as blood, serum, plasma or
urine. However, it is not necessarily limited to these purposes. The analysis
of virtually any biologically active substance in any place in the body can
generally be defined as clinical immunoassay testing. In fact, traditional
specialization barriers, such as microbiology, hematology, blood banking,
immunology and even anatomical pathology are fading rapidly, both
operationally and instrumentally. This TriMark Publications report deals with
the traditional scope of clinical immunoassay, while looking at the emerging
technology trends in this sector. The purpose of this study is to describe the
specific segments of the global clinical immunoanalyzer instrumentation
market. Within this area, the highly-active segments in terms of innovation
and growth are covered. Specifically, it examines the markets for small labs
and highly-automated large lab platforms, as well as the market for accessory
equipment, such as reagents and supplies. Emphasis is on those companies and
products that are actively developing and marketing immunoanalyzer products
for clinical setting, including hospitals, independent labs, physician' s
offices and clinics.
Table of Contents
1. Overview
- 1.1 Objectives
- 1.2 Methodology
- 1.3 Scope of the Report
- 1.4 Executive Summary
2. IVD Clinical Immunoanalyzer Market
3. IVD Clinical Immunoanalyzer Market Analysis
- 3.1 Markets
- 3.1.1 Global Markets
- 3.1.2 Global Drivers of Clinical Immunoanalyzer Testing
- 3.1.3 Global Outlook
- 3.1.4 U.S. Market
- 3.1.5 European IVD Market
- 3.1.5.1 German Clinical Immunoanalyzer Diagnostic Market
- 3.1.5.2 U.K. Clinical Immunoanalyzer Testing Diagnostic Market
- 3.1.5.3 French Clinical Laboratory Diagnostic Testing Market
- 3.1.5.4 Italian Clinical Immunochemistry Diagnostic Market
- 3.1.5.5 Spanish Immunoanalyzer Market
- 3.1.5.6 Finnish Immunoanalyzer Market
- 3.1.5.7 Belgian Immunoanalyzer Market
- 3.1.5.8 Swiss Immunoanalyzer Market
- 3.1.5.9 Dutch Immunoanalyzer Market
- 3.1.5.10 Portuguese Immunoanalyzer Market
- 3.1.5.11 Austrian Immunoanalyzer Market
- 3.1.5.12 Greek Immunoanalyzer Market
- 3.1.5.13 Polish Immunoanalyzer Market
- 3.1.5.14 Romanian Immunoanalyzer Market
- 3.1.6 Country Clinical Analyzer Smaller Markets
- 3.1.6.1 Canadian Clinical Analyzer Market
- 3.1.6.2 Brazilian Clinical Analyzer Market
- 3.1.6.3 Turkish Clinical Immunoanalyzer Market
- 3.1.6.4 Australian Clinical Analyzer Market
- 3.1.6.5 Rest of the World Clinical Analyzer Testing Market
- 3.1.7 Overview of Asian Healthcare Market
- 3.1.7.1 Japanese Clinical Immunoanalyzer Testing Market
- 3.1.7.2 Chinese Clinical Analyzer Market
- 3.1.7.3 Indian Clinical Chemistry Diagnostic Market
- 3.1.7.3.1 India' s In Vitro Diagnostic Testing Industry
- 3.1.8 Overview of the Latin American Diagnostics Market
- 3.2 Clinical Immunoanalyzer Sector
- 3.2.1 Industry-served Markets
- 3.2.2 Industry Players
- 3.2.2.1 Manufacturing Companies
- 3.2.3 Market Specialization
- 3.2.4 Revenue and Reimbursement
- 3.2.5 Companies
- 3.3 Outlook for Clinical Immunoanalyzer Testing
- 3.3.1 Long-term Changes
- 3.3.2 Market Drivers
- 3.3.3 The Limits to Growth
- 3.3.4 Hot Sectors in IVD Market
- 3.3.5 Key Technologies
- 3.3.6 Analyzer Integration Chemistry/Immunoassay
- 3.3.7 Conclusion
4. Clinical Immunoanalyzer Instrument Market by Sector
- 4.1 Market Analysis: Size, Growth, Share and Competitors
- 4.1.1 Immunochemistry Analyzers
- 4.1.2 Large- and Mid-Volume Immunochemistry Analyzers
- 4.1.2.1 Abbott Diagnostics
- 4.1.2.2 Siemens Medical Solutions Diagnostics
- 4.1.2.3 Beckman Coulter, Inc.
- 4.1.2.4 Dade Behring (Acquired by Siemens)
- 4.1.2.5 Diagnostics Products Corporation (Acquired by Siemens
Healthcare Diagnostics)
- 4.1.2.6 Olympus America, Inc. (now Beckman Coulter)
- 4.1.2.7 Ortho-Clinical Diagnostics
- 4.1.2.8 Roche Diagnostics Corp.
- 4.1.2.9 Tosoh Bioscience, Inc.
- 4.1.3 Batch-type Immunoassay Analyzers
- 4.1.3.1 Bio-Rad
- 4.1.3.2 Diamedix
- 4.1.3.3 Tosoh
- 4.1.4 Small- to Mid-Volume Immunoassay Analyzers
- 4.1.4.1 Awareness Technology, Inc.
- 4.1.4.2 Siemens Healthcare Diagnostics, Inc.
- 4.1.4.3 Beckman Coulter, Inc.
- 4.1.4.4 bioMerieux SA
- 4.1.4.5 Dade Behring (Acquired by Siemens)
- 4.1.4.6 Randox Laboratories Ltd.
- 4.1.4.7 Tosoh Corporation
- 4.1.5 Other Immunoassay Analyzers
- 4.1.5.1 Inverness Medical Professional Diagnostics
- 4.1.5.2 Hycor BioMedical (A Part of Agilent Technologies)
- 4.1.5.3 Phadia AB
- 4.1.5.4 Trinity Biotech Plc
- 4.1.5.5 DiaSorin
- 4.1.5.6 Grifols U.S.A., Inc.
- 4.1.5.7 Bio-Rad Laboratories, Inc.
- 4.1.5.8 SFRI Diagnostics
- 4.1.5.9 Qualigen, Inc.
- 4.1.5.10 PerkinElmer, Inc.
- 4.1.5.11 Innotrac Diagnostics Oy
- 4.1.5.12 Tecan Group Ltd.
5. Important Technology Trends
- 5.1 Technology Innovations in Immunoassay Testing
- 5.2 Immunoassay Detection Technology Platforms
- 5.2.1 Fluorescence Detection
- 5.2.2 Chemiluminescence Detection
- 5.3 The New Paradigm
- 5.4 Consolidated Workstations
- 5.5 Automation in the Laboratory in Response to Labor Shortages
- 5.6 Laboratory Information System (LIS)
- 5.7 Biosensor Technology
- 5.8 Data Management Issues
- 5.8.1 Wireless LANs
- 5.8.2 Data and Workflow Management Systems
- 5.8.3 Beckman Central Command
- 5.8.4 Advances in Information Management
- 5.8.5 Connectivity Platforms
- 5.8.5.1 Laboratory Data Linking Software and Interface to the
Laboratory Information System
- 5.8.5.2 Abbott Link Analyzer Connections
- 5.8.5.3 Beckman Coulter DL2000 Data Manager v6.5
- 5.8.5.4 bioMerieux, Inc. ENQ
- 5.8.5.5 Ortho-Clinical Diagnostics, Inc. e-Connectivity Interactive
System Management
- 5.8.6 DataLink Data Management System
- 5.8.7 LifeScan Electronic Data Interfaces
- 5.8.8 Technical Problems of Connectivity
- 5.8.9 Web-based Data Interface and Internet Connectivity
- 5.8.10 HIT Competition
- 5.8.11 FDA-required Software Verification
- 5.8.12 Advantages of Connectivity
- 5.8.13 Technologies for Internet-based Remote Architecture
- 5.8.14 Abbott Multi-tiered Internet System
6. Business Trends in Clinical Immunoanalyzer Sector
- 6.1 Key Developments
- 6.2 Sector Consolidation
- 6.3 Diagnostic Testing Growth Trends
- 6.4 Reagents and Hardware Business in Japan
- 6.5 New Products
- 6.6 Acquisitions, License Agreements, Internal Developments and
Partnerships
- 6.7 Product Testing Depth in Clinical Immunoanalyzer Testing
- 6.8 Government Regulations
- 6.8.1 U.S. Government Regulations
- 6.8.1.1 Importing Medical Devices into the U.S.
- 6.8.1.2 Exporting Medical Devices from the U.S.
- 6.8.2 U.K. Regulations
- 6.8.3 E.U. Regulations
- 6.8.4 Japanese Regulations
- 6.8.5 Korean Regulations
- 6.9 Increased Market Penetration
- 6.10 Costs of Doing Business in Europe
- 6.11 Drivers of European Diagnostics Testing
- 6.12 European Reimbursement Practices
- 6.13 Cost Containment in Europe
- 6.14 Medicare Spending Trends/Medicare Part B Spending Trends
- 6.15 Connectivity Consortium
7. Company Profiles
- 7.1 Abbott Diagnostics
- 7.2 Beckman Coulter, Inc.
- 7.3 bioMerieux
- 7.4 Dade Behring (Acquired by Siemens)
- 7.5 Bio-Rad Laboratories, Inc.
- 7.6 Olympus America, Inc.
- 7.7 Ortho-Clinical Diagnostics, Inc.
- 7.8 Phadia AB
- 7.9 Randox Laboratories Ltd.
- 7.10 Roche
- 7.11 Tosoh Corporation
- 7.12 Siemens AG
8. Clinical Immunoanalyzer Testing Sector: Trends and Forecasts
- 8.1 Automated Instrument Platforms Evolution
- 8.2 Reagents and Supplies Market for Clinical Lab Instruments
- 8.3 Bar Code Reading
- 8.4 Measurement and Detection for Immunoassay Analyzers
- 8.5 Robotics Systems
- 8.6 Move Away from Central Laboratory
- 8.7 Modular Automation
- 8.8 Components of Immunoassay Analyzers
- 8.8.1 The User Interface
- 8.8.2 Display and Data Entry
- 8.8.3 Loading and Unloading
- 8.8.4 Sample Input and Handling
- 8.8.5 Fluidics
- 8.8.6 Processing
- 8.8.6.1 Agitation and Mixing
- 8.8.6.2 Temperature Control and Incubation
- 8.8.6.3 Separation
- 8.8.7 Control and Communications
- 8.8.7.1 Instrument Control
- 8.8.7.2 Scheduling
- 8.8.7.3 Communications and Data Management
- 8.9 Drivers of Clinical Immunoanalyzer Testing
- 8.10 Confluence of New Technology
- 8.11 New Trends in Clinical Laboratory Testing
- 8.11.1 Trends in Reimbursement Practices
- 8.11.2 Managed Care
- 8.11.3 Changes in Patient Management
- 8.11.4 Focused Testing
- 8.11.5 Spending for Clinical Laboratory Testing
- 8.11.6 Reimbursement Pressure
- 8.11.7 Multiplexing Technology
9. Product Launches
- 9.1 Immunoassay Analyzer Product Launches
- 9.2 Immunoassay Reagent Product Launches
INDEX OF FIGURES
- Figure 3.1: Chinese IVD Market, 2006-2012
- Figure 3.2: Lab Revenue by Lab Type
- Figure 3.3: Lab Revenue by Test Type
- Figure 6.1: Part B Spending on Clinical Laboratory Services, 1991- 2007
INDEX OF TABLES
- Table 2.1: Common Immunoassay Tests
- Table 3.1: Worldwide IVD Testing Market, 2009
- Table 3.2: Worldwide Geographic Distribution of IVD Testing, 2009
- Table 3.3: Global Clinical Immunoassay Revenues, 2000-2012
- Table 3.4: Worldwide Distribution of Clinical Immunoassay Testing, 2009
- Table 3.5: U.S. Clinical Laboratory Testing Market, 2003-2012
- Table 3.6: U.S. Clinical Laboratory Diagnostic Test Market Retail Value
Segments, 2008
- Table 3.7: U.S. Clinical Immunoanalyzer Testing Market, 2009-2015
- Table 3.8: European Clinical Laboratory Testing IVD Reagents and
Instruments Market, 2000-2012
- Table 3.9: European Clinical Laboratory Diagnostic Reagents and
Instruments Markets by Analyte, 2008
- Table 3.10: European Clinical Laboratory Testing Diagnostics by Country
Market Estimates, 2007
- Table 3.11: The European Immunochemistry Market, 2001-2012
- Table 3.12: European Immunochemical Reagents and Instruments Markets by
Country, 2006
- Table 3.13: German Clinical Laboratory Testing Diagnostics Products Market
Sales, 2003-2012
- Table 3.14: German Clinical Immunochemistry Testing Diagnostics Products
Market Sales, 2006-2012
- Table 3.15: U.K. Clinical Immunochemistry Testing Diagnostics Products
Market Sales, 2006-2012
- Table 3.16: French Clinical Immunochemistry Testing Diagnostics Products
Market Sales, 2006-2012
- Table 3.17: Italian Immunochemistry Diagnostics Products Market Sales,
2006-2012
- Table 3.18: Spanish Clinical Laboratory Diagnostics Products Market Sales,
2006-2012
- Table 3.19: Finnish Clinical Immunoassay Products Market Sales, 2006-2012
- Table 3.20: Belgian Clinical Immunoassay Products Market Sales, 2006-2012
- Table 3.21: Swiss Clinical Immunoassay Products Market Sales, 2006-2012
- Table 3.22: Dutch Clinical Immunoassay Products Market Sales, 2006-2012
- Table 3.23: Portuguese Clinical Immunoassay Products Market Sales,
2006-2012
- Table 3.24: Austrian Clinical Immunoassay Products Market Sales, 2006-2012
- Table 3.25: Greek Clinical Immunoassay Products Market Sales, 2006-2012
- Table 3.26: Polish Clinical Immunoassay Products Market Sales, 2006-2012
- Table 3.27: Romanian Clinical Immunoassay Products Market Sales, 2006-2012
- Table 3.28: Canadian Clinical Analyzer Testing Market, 2000-2009
- Table 3.29: Brazilian Clinical Immunoanalyzer Testing Market, 2000-2009
- Table 3.30: Turkish Clinical Analyzer Testing Market, 2000-2009
- Table 3.31: Australian Clinical Immunoanalyzer Testing Market, 2000-2009
- Table 3.32: ROW Clinical Immunoanalyzer Testing Market, 2000-2009
- Table 3.33: Japanese Clinical Immunoanalyzer Testing Market, 2000-2009
- Table 3.34: Drivers of Growth in the Chinese Clinical Laboratory Market
- Table 3.35: Number of Chinese Medical Institutions
- Table 3.36: Chinese Clinical Diagnostic Products Market, 2000-2008
- Table 3.37: Chinese Clinical Laboratory Diagnostics Products Market Sales,
2003-2012
- Table 3.38: Chinese IVD Market, 2008
- Table 3.39: Market Share of Reagent Imports into the Chinese Clinical Lab
Market by Country of Origin
- Table 3.40: Market Share of Analytical Instrument Imports into the Chinese
Clinical Lab Market by Country of Origin
- Table 3.41: Chinese International IVD Manufacturers
- Table 3.42: Chinese Domestic IVD Manufacturers
- Table 3.43: Chinese IVD Distributors
- Table 3.44: Indian IVD Market, 2006-2012
- Table 3.45: Number of Automated Clinical Labs in India, 2004-2012
- Table 3.46: Indian IVD Market, 2009
- Table 3.47: Indian IVD Market for Instruments and Reagents, 2004-2012
- Table 3.48: Estimated Number of Clinical Laboratories in Latin America
- Table 3.49: U.S. Clinical Laboratory Testing Sector Revenue, 2005-2015
- Table 3.50: U.S. Clinical Laboratory Testing Sector Segments, 2009
- Table 3.51: Esoteric Tests Performed in the Clinical Laboratory
- Table 3.52: Growth Rates of Test Types
- Table 3.53: Drivers of Clinical Lab Testing Volume
- Table 3.54: Principal Marketers of Automated Clinical Immunoanalyzer
Instruments
- Table 4.1: Samples and Sample Handling Features of Centaur CP
- Table 4.2: Large- and Mid-Size Immunochemistry Analyzers
- Table 4.3: Small- to Mid-Volume Immunoassay Analyzers
- Table 5.1: Analytical Detection Levels for Drugs of Abuse
- Table 5.2: Wireless LAN Technology Companies
- Table 5.3: Applications for Wireless LAN Technology
- Table 5.4: Key Benefits of Laboratory Connectivity Platforms
- Table 5.5: Connectivity Interface Platforms for Clinical Chemistry
Analyzers
- Table 5.6: CAP and JCAHO Requirements for Customized Reporting
- Table 6.1: Hospital Laboratory Share of Part B Medicare Spending, 1996-2006
- Table 6.2: Medicare Part B Spending Per Medicare Enrollee, 1998-2009
- Table 6.3: Allowed Charges for Top 25 Clinical Laboratory Procedures, 2009
- Table 8.1: Technology Platforms for Analyzer Detection Systems
- Table 8.2: Key Criteria for Assessing Data Management Capabilities of
Automated Instruments for Immunochemistry Testing
- Table 8.3: Medicare Billing Guidelines for Multi-Channel Immunoanalyzer
Tests
|
